Dentsply Sirona (XRAY) shares surged 6.14% in pre-market trading on Thursday following the release of its impressive first-quarter 2025 financial results. The dental equipment and supplies manufacturer significantly outperformed analyst expectations, demonstrating robust growth and operational efficiency.
The company reported adjusted earnings per share (EPS) of $0.43, handily beating the analyst estimate of $0.30. This represents a substantial 43% surprise to the upside. Revenue for the quarter came in at $879 million, surpassing the consensus estimate of $854.75 million and showcasing strong demand for Dentsply Sirona's products and services.
Despite the challenging economic environment, Dentsply Sirona remains confident in its outlook. The company announced that it is maintaining its full-year 2025 guidance for organic sales and adjusted EPS, signaling continued optimism about its business performance. This positive earnings report and sustained outlook have likely contributed to investor enthusiasm, driving the stock's pre-market rally.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。